Literature DB >> 32928830

Acute liver failure masquerading an occult malignancy.

Pooja Gogia1, Sotirios Doukas2, Marcus Porcelli3, Tricia Gilbert4.   

Abstract

Acute liver failure (ALF) is a rare initial presentation of metastatic liver disease and is associated with high fatality. Our case report describes acute hepatic decompensation from an occult pancreatic malignancy. A 64-year-old man presented with abdominal distension for 2 weeks associated with decreased appetite and a weight loss of 13.6 kg, over the past 8 months. Significant admission labs were serum creatinine: 6.15 mg/dL, serum bilirubin: 27 mg/dL, aspartate aminotransferase (AST): 316 u/L, alanine aminotransferase (ALT): 198 u/L and serum alkaline phosphatase: 2121 u/L. He was admitted to the medical intensive care unit and was started on dialysis for acute renal failure. MRI of the abdomen showed multiple masses in the liver concerning for metastatic disease, cystic lesions in the pancreatic body and ascites. He underwent paracentesis and ascitic fluid analysis was positive for adenocarcinoma. CA 19-9 was 17 828 u/mL. The patient's condition gradually deteriorated, and he died of cardiac arrest. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer - see oncology; pancreatic cancer

Mesh:

Year:  2020        PMID: 32928830      PMCID: PMC7490937          DOI: 10.1136/bcr-2020-235935

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Fatal acute liver failure in a child with metastatic gastric adenocarcinoma.

Authors:  Sunny Zaheed Hussain; Arti Jaiswal; Ali Amjed Bader; Parvathi Mohan; Bruce M Markle; Caterina Minnitti; Ronald Przygodzki; Benny Kerzner; Stuart S Kaufman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

2.  Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of "pseudocirrhosis".

Authors:  David A Sass; Kenneth Clark; Dana Grzybicki; Mordechai Rabinovitz; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

Review 3.  Acute liver failure.

Authors:  William Bernal; Julia Wendon
Journal:  N Engl J Med       Date:  2013-12-26       Impact factor: 91.245

4.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  Metastatic breast cancer presenting as acute liver failure.

Authors:  Hector E Nazario; Rita Lepe; James F Trotter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-01

Review 6.  Surviving at a Distance: Organ-Specific Metastasis.

Authors:  Anna C Obenauf; Joan Massagué
Journal:  Trends Cancer       Date:  2015-09-28

7.  Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.

Authors:  William M Lee; R Todd Stravitz; Anne M Larson
Journal:  Hepatology       Date:  2012-03       Impact factor: 17.425

8.  Fulminant Hepatic Failure due to Primary Hepatic Lymphoma: a Case Report.

Authors:  Zahedin Kheyri; Ali Ali Asgari; Ali Zare Mehrjerdi; Farhad Zamani; Hossein Ajdarkosh
Journal:  Middle East J Dig Dis       Date:  2013-07

9.  Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.

Authors:  Takatsugu Ogata; Yuichiro Kikawa; Misato Ogata; Hironaga Satake; Yukimasa Hatachi; Hisateru Yasui
Journal:  Case Rep Oncol       Date:  2018-10-31

10.  Radiographically Occult Carcinomatous Spread of Breast Cancer to the Liver: A Challenging Case.

Authors:  Trish Millard; Akriti Gupta; Christiana Brenin; Paul Marshall; Patrick Dillon
Journal:  Case Rep Oncol Med       Date:  2019-12-06
View more
  1 in total

Review 1.  EVA1A Plays an Important Role by Regulating Autophagy in Physiological and Pathological Processes.

Authors:  Shizhen Zhao; Honggang Wang
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.